Kashif Ali Khan is a pharmacy researcher and Pharm-D scholar at Shaheed Benazir Bhutto University, Sheringal, Pakistan, with research interests spanning clinical pharmacy, oncology, nanomedicine and drug delivery, neuropharmacology, antimicrobial resistance, and translational healthcare research. His clinical training includes experience at the Pakistan Atomic Energy Cancer Hospital (SINOR) in oncology pharmacy, oncology wards, nuclear medicine, and radiotherapy. He has contributed to research publications with international publishers, including Springer Nature and Bentham Science, particularly in cancer nanotechnology and Alzheimer’s disease therapeutics.
Selected Publications
1. Khan, K. A., et al. (2025). Applications of Au Nanoparticles as drug delivery and theranostic nanoplatforms in cancer therapy: A comprehensive review. Polymer Bulletin, 82, 12417–12484. Springer Nature. The paper examines gold nanoparticles for cancer drug delivery, diagnostics, imaging, and theranostic applications. ResearchGate
Publication link: Springer / DOI: 10.1007/s00289-025-06015-8
2. Khan, K. A., et al. (2025). Conventional and Emerging Drug Targeting Sites in Alzheimer’s Disease and the Role of Translational Informatics in its Diagnosis and Management. Current Neuropharmacology, 23(14), 1894–1917. The review covers conventional and emerging therapeutic targets for Alzheimer’s disease alongside translational informatics, predictive analytics, and explainable AI. PubMed Central (PMC)
Publication link: PubMed – PMID 40207764 | DOI: 10.2174/011570159X361867250313073624